Cefotetan - Revision history

Danbot: Remove disease-specific entries now covered by AntibioticDose (6 sections)

2026-03-20T11:08:22Z

Remove disease-specific entries now covered by AntibioticDose (6 sections)

← Older revision		Revision as of 11:08, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
	~~===[[Infection]]===~~
	*Mild to Moderate, Bacterial
	**1-2 g IM/IV q12h
	***Max: 4 g/day
	*Severe to Life Threatening, Bacterial
	**2-3 g IV q 12h
	***Max: 6 g/day
	~~===[[UTI]], uncomplicated===~~
	*500 mg IM/IV q12h
	~~===Prophylaxis===~~
	*Surgical:
	**2 g IV x1
	*Postcesarean:
	**2 g IV x1


Line 36:		Line 22:

	==Pediatric Dosing==		==Pediatric Dosing==
	~~===[[Infection]], bacterial===~~
	*40-80 mg/kg/day IM/IV divided q12h
	**Max: 4 g/day or 6 g/day in life-threatening infection
	~~===[[PID]], severe===~~
	*Adolescents
	**2g IV q12h with [[doxycycline]]
	~~===Prophylaxis===~~
	*Surgical, >1yo
	**40 mg/kg IV x1

Danbot: Remove disease-specific dosing covered by dynamic SMW tables

2026-03-20T02:58:00Z

Remove disease-specific dosing covered by dynamic SMW tables

← Older revision		Revision as of 02:58, 20 March 2026
Line 16:		Line 16:
	===[[UTI]], uncomplicated===		===[[UTI]], uncomplicated===
	*500 mg IM/IV q12h		*500 mg IM/IV q12h
	~~===[[PID]], severe===~~
	*2 g IV q12h with [[doxycycline]]
	===Prophylaxis===		===Prophylaxis===
	*Surgical:		*Surgical:

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:38:45Z

Restore original dosing content alongside dynamic SMW tables

← Older revision		Revision as of 02:38, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
			===[[Infection]]===
			*Mild to Moderate, Bacterial
			**1-2 g IM/IV q12h
			***Max: 4 g/day
			*Severe to Life Threatening, Bacterial
			**2-3 g IV q 12h
			***Max: 6 g/day
			===[[UTI]], uncomplicated===
			*500 mg IM/IV q12h
			===[[PID]], severe===
			*2 g IV q12h with [[doxycycline]]
			===Prophylaxis===
			*Surgical:
			**2 g IV x1
			*Postcesarean:
			**2 g IV x1


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			===[[Infection]], bacterial===
			*40-80 mg/kg/day IM/IV divided q12h
			**Max: 4 g/day or 6 g/day in life-threatening infection
			===[[PID]], severe===
			*Adolescents
			**2g IV q12h with [[doxycycline]]
			===Prophylaxis===
			*Surgical, >1yo
			**40 mg/kg IV x1


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:41Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Older revision		Revision as of 01:52, 20 March 2026
Line 7:		Line 7:

	==Adult Dosing==		==Adult Dosing==
	===~~[[Infection]]~~===		===Indications by Disease===
	*Mild to Moderate, Bacterial		{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Adult]]
	**1-2 g IM/IV q12h		\|?Treats disease=Disease
	***Max: 4 g/day		\|?Has Dose=Dose
	*Severe to Life Threatening, Bacterial		\|?Has Context=Context
	**2-3 g IV q 12h		\|format=table
	***Max: ~~6 g/day~~		\|limit=50
	~~===~~[[~~UTI~~]]~~, uncomplicated===~~		\|mainlabel=-
	*500 mg IM/IV q12h		\|headers=show
	~~===~~[[~~PID~~]]~~, severe~~===		\|sort=Treats disease
	*2 g IV q12h with [[doxycycline]]		}}
	===~~Prophylaxis~~===
	*Surgical:
	**2 g IV x1
	*Postcesarean:
	**2 g IV x1

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~[[Infection]], bacterial~~===		===Indications by Disease===
	*40-80 mg/kg/day IM/IV divided q12h		{{#ask: [[Has DrugName::Cefotetan]] [[Has Population::Pediatric]]
	**Max: ~~4 g/day or 6 g/day in life-threatening infection~~		\|?Treats disease=Disease
	~~===~~[[~~PID~~]]~~, severe===~~		\|?Has Dose=Dose
	*Adolescents		\|?Has Context=Context
	**2g IV q12h with [[~~doxycycline~~]]		\|format=table
	===~~Prophylaxis~~===		\|limit=50
	*Surgical, >1yo		\|mainlabel=-
	**40 mg/kg IV x1		\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

Ostermayer at 16:10, 18 July 2025

2025-07-18T16:10:29Z

← Older revision		Revision as of 16:10, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: ~~Second~~ generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::2nd generation]] [[Is DrugClass::cephalosporin]]
	*Dosage Forms: injectable solution, powder for injection		*Dosage Forms: injectable solution, powder for injection
	*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 1g, 2g, 10g		*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 1g, 2g, 10g

Ostermayer at 14:50, 18 July 2025

2025-07-18T14:50:51Z

← Older revision		Revision as of 14:50, 18 July 2025
Line 1:		Line 1:
	==General==		==General==
	*Type: Second generation [[cephalosporin]]		*Type: Second generation [[Is DrugClass::cephalosporin]]
	*Dosage Forms: injectable solution, powder for injection		*Dosage Forms: injectable solution, powder for injection
	*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 1g, 2g, 10g		*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 1g, 2g, 10g

ClaireLewis at 21:51, 19 September 2019

2019-09-19T21:51:37Z

← Older revision		Revision as of 21:51, 19 September 2019
Line 223:		Line 223:
	<references/>		<references/>

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Mholtz: Text replacement - "w/" to "with"

2018-06-10T04:28:47Z

Text replacement - "w/" to "with"

← Older revision		Revision as of 04:28, 10 June 2018
Line 90:		Line 90:

	==Pharmacology==		==Pharmacology==
	*Half-life: 3-4.6h (10h w/ moderate renal impairment)		*Half-life: 3-4.6h (10h with moderate renal impairment)
	*Metabolism: Minimal		*Metabolism: Minimal
	*Excretion: Urine primarily (51-81% unchanged)		*Excretion: Urine primarily (51-81% unchanged)

Humanguy: edited dosage forms, strengths, routes of administration

2017-10-13T17:59:15Z

edited dosage forms, strengths, routes of administration

← Older revision		Revision as of 17:59, 13 October 2017
Line 1:		Line 1:
	==General==		==General==
	*Type: Second generation [[cephalosporin]]		*Type: Second generation [[cephalosporin]]
	*Dosage Forms: IV, IM		*Dosage Forms: injectable solution, powder for injection
			*Dosage Strengths: injectable solution: 20mg/mL, 40mg/mL; powder for injection: 1g, 2g, 10g
			*Routes of Administration: IV, IM
	*Common Trade Names: Cefotan		*Common Trade Names: Cefotan

Rossdonaldson1: /* Adverse Reactions */

2017-09-17T18:18:34Z

Adverse Reactions

← Older revision		Revision as of 18:18, 17 September 2017
Line 71:		Line 71:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*Hypersensitivity ~~rxn~~		*Hypersensitivity reaction
	*[[Anaphylaxis]]		*[[Anaphylaxis]]
	*[[Stevens-Johnson Syndrome]], toxic epidermal necrolysis		*[[Stevens-Johnson Syndrome]], toxic epidermal necrolysis
Line 86:		Line 86:
	*[[Pruritus]], [[Rash]], [[Phlebitis]], [[Urticaria]]		*[[Pruritus]], [[Rash]], [[Phlebitis]], [[Urticaria]]
	*Increased LFTs		*Increased LFTs

	==Pharmacology==		==Pharmacology==
	*Half-life: 3-4.6h (10h w/ moderate renal impairment)		*Half-life: 3-4.6h (10h w/ moderate renal impairment)